Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Nutritional / Metabolic Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Nutritional / Metabolic Other
    Consumption of Nuts, Corn Does Not Increase Risk of Diverticulosis in Men - (DGNews)
    High-Fat Ketogenic Diet Lowers Cholesterol in Children With Epilepsy - (DGNews)
    Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial - (JAMA)
    B Vitamins, Folic Acid Do Not Prevent Death or Cardiovascular Events - (DGNews)
    Grapefruit, Orange, and Apple Juices Lower Absorption of Certain Drugs - (DGNews)

    News archive

     Recent webcasts/CME - Nutritional / Metabolic Other
    • Beyond Glycemic Control: Managing Obesity and Cardiovascular Disease Risk for Patients With Type 2 Diabetes in the Primary Care Setting
    • Choosing a Therapeutic Approach to Early-Onset Schizophrenia: Disease Assessment to Pharmacotherapy
    • Cardiometabolic Risk and Risk Management
      Understanding Metabolic Syndrome: Knowing the Risks
      Food Allergies: When the Food Comes to Bite the Gut

      Webcasts/CME archive

       Recent cases - Nutritional / Metabolic Other
        Hypercalcemia in a Patient with Disseminated Paracoccidioidomycosis: A Case Report
        Symptomatic Hypercalcemia in a Patient with Chronic Tophaceous Gout: A Case Report
        Chronic Hypokalemia Due to Excessive Cola Consumption: A Case Report
        Pituitary Hypoplasia and Growth Hormone Deficiency in a Woman with Glycogen Storage Disease Type Ia: A Case Report
        An Atypical Presentation of Cystic Fibrosis: A Case Report

        Cases archive
          




        my personal edition > nutritional / metabolic other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Calcium and Vitamin D Supplementation Improve Bone Density in HIV-Infected Children on Antiretroviral Therapy: Presented at PAS

        By Rabiya S. Tuma, PhD

        SAN FRANCISCO, C.A. -- May 10, 2006 -- Calcium and vitamin D supplementation improves bone density in children with HIV being treated with antiretroviral therapy, according to data from a retrospective cohort study.

        "Large randomized controlled trials are needed to study this intervention in a prospective manner," said Ethan Leonard, MD, assistant professor of pediatrics, Rainbow Babies and Children's Hospital, Cleveland, Ohio, who presented the work here on May 2nd at the annual meeting of the Pediatric Academic Societies (PAS).

        Dr. Leonard noted that this is the first study to show that supplementation improves bone health in this patient population.

        The retrospective review evaluated children who were 9 years of age or older treated for HIV at the tertiary pediatric hospital. Children received 500 mg of calcium carbonate and 200 IU of ergocalciferol twice daily. Younger patients received half this dose.

        Dr. Leonard and colleagues identified 26 patients who had had at least 2 bone density tests using dual energy X-ray absorptiometry (DEXA). Of those, 18 patients received calcium and vitamin D supplements. Supplementation was at the discretion of the treating physician.

        Mean baseline lumbar Z-score was significantly lower in the treatment group (-2.3, 95% confidence interval [CI], -4.3, -1.1) than in the non-treatment group (-0.9, 95% CI, -1.7, 0.3). Additionally, mean baseline bone mineral density (BMD) was lower in the treatment group (0.6 g/cm2, 95% CI, 0.3, 0.8) compared with the non-treatment group (0.7 g/cm2, 95% CI, 0.5, 1.0).

        After a median of 26 months on therapy, the second DEXA evaluation showed improvement in the treatment group. The mean Z-score for the treatment group had increased significantly to -1.5 (95% CI, -3.3, 1.0) and the mean BMD increased to (0.7 g/cm2, 95% CI, 0.5, 1.0).

        Over the same period of time, there was no significant change in the non-treatment group, with a mean Z-score of -1.1 (95% CI, -1.8, 0.3) at the second DEXA evaluation and a mean BMD of 0.8 g/cm2 (95% CI, 0.5, 1.0).

        Multiple regression analysis showed that the only variable that correlated with improve bone health was supplementation of calcium and vitamin D. Body mass index did not correlate with improvement.

        "Pediatricians should be aware of the high prevalence of decreased bone mineral density in HIV infected children," Dr. Leonard said.

        Antiretroviral therapy was previously shown to disrupt bone metabolism in patients with HIV. However, the problem may be more serious in children who are infected from birth and on antiretroviral therapy throughout their lives.


        [Presentation title: Calcium and Vitamin D Supplementation Ameliorate Bone Loss in HIV Infected Children. Abstract 5523.131]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send